Location History:
- Brisbane, AU (2015)
- Brisband, AU (2017)
Company Filing History:
Years Active: 2015-2017
Title: Innovations of Mei Kwan Yau in Protease Activated Receptors
Introduction
Mei Kwan Yau is an accomplished inventor based in Brisbane, Australia. She has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of protease activated receptors. With a total of 2 patents, her work focuses on developing novel compounds that can be utilized in biological studies and therapeutic applications.
Latest Patents
Mei Kwan Yau's latest patents include innovative compounds aimed at modulating Protease Activated Receptor-2 (PAR2). The first patent, titled "Modulators of protease activated receptors," presents novel compounds of the Formula (I) and pharmaceutical compositions that can be used as tools for biological studies or as agents for treating diseases associated with undesirable PAR2 activity. The second patent, "Modulations of protease activated receptors," similarly provides novel compounds and methods for utilizing these compounds in therapeutic contexts.
Career Highlights
Mei Kwan Yau is affiliated with The University of Queensland, where she conducts her research and development work. Her academic background and research focus have positioned her as a key figure in her field, contributing to advancements in understanding and treating disorders linked to PAR2.
Collaborations
Throughout her career, Mei Kwan Yau has collaborated with notable colleagues, including David P Fairlie and Ligong Liu. These collaborations have enhanced her research efforts and expanded the impact of her innovations.
Conclusion
Mei Kwan Yau's work in the modulation of protease activated receptors represents a significant advancement in pharmaceutical research. Her contributions are paving the way for new therapeutic options in treating diseases associated with PAR2 activity.